HH Biotechnology Pink Sheet Forecast - Simple Exponential Smoothing
| HHBT Stock | USD 0.0001 0.00 0.00% |
The Simple Exponential Smoothing forecasted value of HH Biotechnology Holdings on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00000167 and the sum of the absolute errors of 0.0001. HHBT Pink Sheet Forecast is based on your current time horizon.
At this time the relative strength index (rsi) of HH Biotechnology's share price is below 20 . This usually indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using HH Biotechnology hype-based prediction, you can estimate the value of HH Biotechnology Holdings from the perspective of HH Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of HH Biotechnology Holdings on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00000167 and the sum of the absolute errors of 0.0001. HH Biotechnology after-hype prediction price | USD 1.08E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
HHBT |
HH Biotechnology Additional Predictive Modules
Most predictive techniques to examine HHBT price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for HHBT using various technical indicators. When you analyze HHBT charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
HH Biotechnology Simple Exponential Smoothing Price Forecast For the 24th of January
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of HH Biotechnology Holdings on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00000167, mean absolute percentage error of 0, and the sum of the absolute errors of 0.0001.Please note that although there have been many attempts to predict HHBT Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that HH Biotechnology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
HH Biotechnology Pink Sheet Forecast Pattern
| Backtest HH Biotechnology | HH Biotechnology Price Prediction | Buy or Sell Advice |
HH Biotechnology Forecasted Value
In the context of forecasting HH Biotechnology's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. HH Biotechnology's downside and upside margins for the forecasting period are 0.000001 and 6.30, respectively. We have considered HH Biotechnology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of HH Biotechnology pink sheet data series using in forecasting. Note that when a statistical model is used to represent HH Biotechnology pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 93.7576 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0167 |
| SAE | Sum of the absolute errors | 1.0E-4 |
Predictive Modules for HH Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as HH Biotechnology Holdings. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.HH Biotechnology After-Hype Price Prediction Density Analysis
As far as predicting the price of HH Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in HH Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of HH Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
HH Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting HH Biotechnology's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on HH Biotechnology's historical news coverage. HH Biotechnology's after-hype downside and upside margins for the prediction period are 0.00 and 6.30, respectively. We have considered HH Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
HH Biotechnology is out of control at this time. Analysis and calculation of next after-hype price of HH Biotechnology Holdings is based on 3 months time horizon.
HH Biotechnology Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as HH Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading HH Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with HH Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.79 | 6.30 | 0.00 | 0.00 | 0 Events / Month | 1 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0001 | 0.0001 | 8.45 |
|
HH Biotechnology Hype Timeline
HH Biotechnology Holdings is currently traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. HHBT is forecasted to increase in value after the next headline, with the price projected to jump to 1.08E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price appreciation on the next news is estimated to be 8.45%, whereas the daily expected return is currently at -0.79%. The volatility of related hype on HH Biotechnology is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has return on total asset (ROA) of 0.0502 % which means that it generated a profit of $0.0502 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0945 %, meaning that it created $0.0945 on every $100 dollars invested by stockholders. HH Biotechnology's management efficiency ratios could be used to measure how well HH Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Historical Fundamental Analysis of HH Biotechnology to cross-verify your projections.HH Biotechnology Related Hype Analysis
Having access to credible news sources related to HH Biotechnology's direct competition is more important than ever and may enhance your ability to predict HH Biotechnology's future price movements. Getting to know how HH Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how HH Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MHPC | Manufactured Housing Properties | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ACAN | Americann | 0.00 | 2 per month | 0.00 | 0.06 | 0.00 | 0.00 | 250.00 | |
| EGRNF | EGRNF | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BRER | Bresler Reiner | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 233.33 | |
| SFRT | Appreciate Holdings | 0.00 | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EHPTP | Eagle Hospitality Properties | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AGTK | Agritek Holdings | 0.00 | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CRXPF | Vert Infrastructure | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| XXFPL | FFP Partners LP | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| COWPP | Canal Capital | 0.00 | 7 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for HH Biotechnology
For every potential investor in HHBT, whether a beginner or expert, HH Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. HHBT Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in HHBT. Basic forecasting techniques help filter out the noise by identifying HH Biotechnology's price trends.HH Biotechnology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with HH Biotechnology pink sheet to make a market-neutral strategy. Peer analysis of HH Biotechnology could also be used in its relative valuation, which is a method of valuing HH Biotechnology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
HH Biotechnology Market Strength Events
Market strength indicators help investors to evaluate how HH Biotechnology pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading HH Biotechnology shares will generate the highest return on investment. By undertsting and applying HH Biotechnology pink sheet market strength indicators, traders can identify HH Biotechnology Holdings entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
HH Biotechnology Risk Indicators
The analysis of HH Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in HH Biotechnology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting hhbt pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.49 | |||
| Standard Deviation | 6.15 | |||
| Variance | 37.88 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for HH Biotechnology
The number of cover stories for HH Biotechnology depends on current market conditions and HH Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that HH Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about HH Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for HHBT Pink Sheet Analysis
When running HH Biotechnology's price analysis, check to measure HH Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HH Biotechnology is operating at the current time. Most of HH Biotechnology's value examination focuses on studying past and present price action to predict the probability of HH Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HH Biotechnology's price. Additionally, you may evaluate how the addition of HH Biotechnology to your portfolios can decrease your overall portfolio volatility.